Jul 29, 2017

University of Missouri Team Develops Non-toxic Gold Nanoparticles for Ayurveda Treatment

An Indian American professor, Kattesh Katti, and his research team at the University of Missouri have partnered with Tamil Nadu-based company Dhanvantari Nano Ayushadi in hopes of revolutionizing Ayurvedic medicine.
Ayurvedic medicine, also called Ayurveda, is a holistic medicine system originated in India thousands of years ago that uses herbal compounds, special diets and other healthcare practices to further help conventional preventative and disease treatments, according to a Missouri news release.
Katti and his team have developed a non-toxic delivery method using gold nanoparticles that may revolutionize Ayurveda, the news release said. His technique for producing the nanoparticles was licensed by Dhanvantari Nano Ayushadi.
The medicine uses different combinations of chemicals from natural herbs, spices, fruits and vegetables in combination with metals such as gold, silver and copper, the university said
The combinations strive to treat a number of disorders.
“In the past, metals predominantly used in holistic medicine have been crushed and burned; caregivers grind the ash with herbs to produce an ingestible treatment,” Katti, the curators distinguished professor of radiology and physics in the MU School of Medicine and the College of Arts and Science and senior research scientist at the University of Missouri Research Reactor, said in a statement.
“However, the ways in which those metals are procured often involve mercury; other toxic means to extract the gold or other alloys can be deadly if ingested in the wrong amounts. The gold nanoparticle production methods use a green technology that effectively eliminates the toxicity associated with these treatments,” Katti added.
The research team developed green nanotechnologies to produce phytonano medicines — the compounds used to form Ayurvedic medicine. The therapies are less toxic to the body and could provide alternatives to current treatments for diseases including cancer, arthritis and diabetes among others, the news release noted.
The technology is patent pending.
“These successful production runs within the DNA premises and the efficient training of our personnel fully fulfill the requirements signed in our contract,” Abhaya Kumar Jain, chief executive of DNA, said in a statement.
“We look forward to a long-term working and collaborative relationship with Dr. Katti and his team as we collectively advance the field of nano-Ayurvedic medicine to develop the next generation of health care products for the care and treatment of patients across the world,” Jain added.
Research and product development using the green nanotechnology techniques developed in Katti’s lab will continue at the facility in India, according to the university.
Using Indian Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy guidelines, DNA will continue to test formulations that could provide complementary therapies to chemotherapy, radiation and other traditional treatments, Katti said in the report.
“We are excited that two great minds, Mr. Abhaya Kumar Jain, a pioneer in the Indian pharmaceutical industry, and Professor Kattesh V Katti, globally recognized as the ‘father of green nanotechnology,’ have come together to bring nano-Ayurvedic medicine technology to India,” Anantkumar Hegde, an elected member of the Indian Parliament, said in the report.
Added Katti in the report, “The nano-Ayurvedic medicine approaches are built on rigorous scientifically validated methods. I am excited to be a part of this important journey using nano-Ayurvedic medicine approaches for treating, healing and curing various diseases. I have always dreamed of helping humanity through my science, I can now see that I am able to use my interdisciplinary green nanotechnology approaches for the development of Ayurvedic products.”


Jan 4, 2017

Bhishak Sangama - Ayurveda Practitioners' Meet and One day seminar on Ayurveda Clinical Practice at SDM Bengaluru on 20th Jan 2017 Friday

Cordial invitation to the Ayurveda Practitioners of Bengaluru to "Bhishak Sangama (Bengaluru Ayurveda Practitioners' Meet and one day seminar on Ayurveda clinical practice)" being held on 20th Jan 2017 Friday at SDM Institute of Ayurveda and Hospital, Anchepalya, Mysore Road, Bengaluru - 74. Intended to become a platform to refresh the knowledge of classical guidelines for the Ayurveda clinical practice and to share the clinical experiences with the members of fraternity. Please spread a word to reach out the interested practitioners of Ayurveda based at Bengaluru. Register soon!


Dec 11, 2016

Govt amends law: Ayurveda, Unani doctors to practice allopathy in MP

, TNN | Dec 9, 2016, 11.13PM IST

BHOPAL: Now Ayurveda and Unani doctors will able to practice allopathic medicines in Madhya Pradesh. Twin bills were passed in the state assembly on Friday to enable these doctors to prescribe allopathic medicines. This is being done to meet out the shortage of doctors , health minister Rustam Singh told the house. 

Two bills-Madhya Pradesh Ayurvigyan parishad (sanshodhan) vidhayak 2016 and MP Ayurvdic ,Unani tatha prakritik chikitsa vyavsai (sanshodhan) vudhayak 2016 were passed on Friday amidst opposition from the Congress. 

Bala Bachchan, acting leader of the opposition said, "Now the affect of Vyapam scame is clear. More than 1000 doctors have been denied their degrees after the scam. The MBBS takes more than 5 years to complete, here you will train them in 3 months only." 

He said that the government would withdraw the bill. 

Ramniwas Rawat, chief whip of the Congress said, "this is highly objectionable. This government is playing with the health of the people. The government has not even taken the permission of medical council of India (MCI)." 

Rawat also said that the government is not paying doctors well which is why no doctor is interested in government job. On the other hand doctors of Deepak foundation of Gujarat working for MP government get Rs 1 lakh salary. 

Bachachan said that "by taking help of Deepak foundation, the government wants privatisation of health services in MP." 

But health minister Rustam Singh assured the house that, "the Ayurveda and Unani doctors will be allowed to practice on 72 medicines. This is a temporary arrangement and as soon as doctors are available this would be withdrawn." 

He said that some states like Maharashtra and Gujarat have also been following this practice. 

Source: http://timesofindia.indiatimes.com/city/bhopal/govt-amends-law-ayurveda-unani-doctors-to-practice-allopathy-in-mp/articleshow/55900828.cms?TOI_browsernotification=true


Oct 30, 2016

UGC tells varsities to start PhD programmes for AYUSH disciplines

The University Grants Commission (UGC) has asked universities to start PhD programmes under Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) disciplines.
In a circular to all Central Universities UGC secretary Jaspal S Sandhu has said the Central Councils set up for research in these disciplines will sponsor 200 students for pursuing PhDs every year.
He also said the government has asked the Commission to issue an advisory in this regard. “AYUSH is aimed at developing Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) systems for healthcare of the people imbibing scientific interventions.
As per the letter, each of these five disciplines conduct clinical and basic research studies in collaboration with reputed scientific institutes:
Central Council for Research in Ayurvedic Sciences Central Council for Research in Homoeopathy
Central Council for Research in Yoga & Naturopathy
Central Council for Research in Unani Medicine
Central Council for Research in Siddha
These Councils further desire to enhance research opportunities through PhD fellowship programme for the development of AYUSH, the UGC letter said.
It is intended to sponsor annually 200 candidates (125 PG of AYUSH and 75 PG of Science & technology streams) for pursuing Ph.D on AYUSH research topics, it added.
“Accordingly, it is requested that you may include AYUSH disciplines in your esteemed university and in the affiliated colleges for enrollment of candidates in the PhD programmes and avail fellowship from the concerned AYUSH Research Council,” the UGC said.


Sep 1, 2016


Writing awards in Ayurveda by Rastriya Ayurveda Vidyapeeth

Entries Invited for awards on popular and scientific writing in Ayurveda Rashtriya Ayurveda Vidyapeeth invites entries for following awards on popular and scientific writing in Ayurveda. These awards are instituted to promote the popular writing in ayurveda for common people in the common language as well as scientific writing in Ayurveda for academicians and researchers in the scientific language. The awards are given in following categories. The last date for submission of entry in each case is 1 January 2017.

Category A: Award for Popular Writing in Ayurveda Two awards are given for popular writing in Ayurveda respectively in Hindi and English . Each award carry a cash prize of Rs.10000/- , a citation and a certificate from RAV. These awards are given to a best piece of writing/ featured article appeared in any national daily, weekly/monthly or quarterly news paper/ periodical during the preceding calander year ( 1 january to 31 december 2016). The published article should have a minimum length of 1000 words .

Category B: Award for Scientific Writing in Ayurveda This award is given in following three categories
a) Student scientific writing award : is given to MD / PhD/ M Phil students of ayurveda for their published research work in a national /international scientific journal of repute. This award may carry a cash prize of Rs. 20000/- , a citation and a certificate from RAV.

 b) Senior scientific writing award : is given to a faculty member, physician, independent researcher or practitioner who has his scientific research published in a national/ international scientific journal of repute. This award carry a cash prize of Rs. 25000/- , a citation and a certificate from RAV.

 c) Scientific writing award for best book / monograph in Ayurveda : This award is given to the best monograph/ book on Ayurveda published during the preceding year. The book should contain a minimum of 100 pages. This award carry a cash prize of Rs. 50000/- , a citation and a certificate from RAV. The publication sould belong to year commensing from 1st Janauary till 31 December 2016.

Following are the general rules for submission of application and selection process for these awards 1. The applicant should have a BAMS or equivalent qualification recognized by CCIM and should be registerd with respective registering authority.
2. Regarding the student category , the applicant should be a bonafied student of a recognized institution at the time of application. A certificate of this intent from the head of the institution is required in this regard.
3. There is no age limit for the applications. Any one of any age can apply in respective categories.
 4. The publication should belong to the preceding year only. Old publications will not be considered. 5. Applications must be submitted on the given format along with four original copies of the publication( photo copies are not allowed). In case of an online publication, a soft copy of the article shall also be submitted.
 6. An undertaking regarding the originality of the publication is required to be submitted along with the application.
7. In case of multiple authors , a consent from each of the author regarding submission of the publication for the award is required.
8. Author once awarded , may not apply in the similar category for next three years.
9. In case of multiple authors, the award sum may be distributed equally among all the authors .
10.A distinct review committee of eminent scholars, journalists and scientist pertaining to Ayurveda will evaluate all the applications in reference to their quality, relevance and aptness for the purpose of award in their respective categories. Best among all will be choosen for the award.
11.The awards will be conferred every year on the day of convocation of RAV.

For more details, please visit, http://ravdelhi.nic.in/


Aug 4, 2016

BIMS, BUMS, BAMS reach Supreme court challenging crosspathy ban

New Delhi: Challenging the Delhi High Court decision of April 8th which clearly specified that BIMS, BUMS, BAMS, and other other practitioners of Indian Systems of Medicine cannot practice modern scientific system of medicine and prescribe allopathic medicines, National Integrated Medical Association and All India Indian Medicine Graduates Association are reported to have filed an appeal with the Supreme Court. The appeal came in the wake of the Delhi high court decision that had struck the clause Section 2(h) of the Delhi Bharatiya Chikitsa Parishad Act, 1998 (DBCP Act) and the Notification No.28-5/2004-Ay. (MM) dated 19th May, 2004 of Central Council of Indian Medicine (CCIM) that on the basis whereof the practitioners of Indian System of Medicine were claiming to have a right to practice in the Allopathic System of Medicine.
During the partial hearing on 1st august, Arguments went on from the side of ISM practitioners, who are being represented by prominent lawyers of the country including Senior Advocates Harish Salve and Raju Ramachandran. The lawyer on behalf of ISM practitioners, that the history of surgery in the world, started with Sushruta who was a noted Ayurvedacharya. Moreover it was argued that, many allopathic drugs including antibiotics are necessary part of treatment/surgeries, which the said practitioners are not being able to prescribe in the wake of the high court judgement in delhi However, considering the current scenario of medical practise in mind the Chief Justice of India, hon’ble Justice TS Thakur, who is hearing the matter did not seem much convinced with the argument, even remarking. “How many of you would go to an Ayurvedacharya for a surgery?” The chief justice has indeed is reported to have shown a great surprise to the contention that ayurivedic practitioner perfo...

Read more at Medical Dialogues: BIMS, BUMS, BAMS reach Supreme court challenging crosspathy ban http://medicaldialogues.in/bims-bums-bams-reach-supreme-court-challenging-crosspathy-ban/